|  | OR (95 % CI) | P-value | OR* (95 % CI) | P *-value |
---|---|---|---|---|---|
Hypoalphalipoproteinemia | |||||
APOE genotype | ε3/ε3 | 1 |  | 1 |  |
ε2 carrier | 1.19 (0.43–3.26) | 0.739 | 1.29 (0.45–3.63) | 0.635 | |
ε4 carrier | 2.68 (1.17–6.14) | 0.020 | 2.78 (1.18–6.58) | 0.020 | |
Hyperbetalipoproteinemia | |||||
APOE genotype | ε3/ε3 | 1 |  | 1 |  |
ε2 carrier | 0.86 (0.29–2.56) | 0.785 | 1.06 (0.33–3.35) | 0.923 | |
ε4 carrier | 2.69 (1.22–5.94) | 0.014 | 2.08 (0.85–5.10) | 0.110 | |
Hypertriglyceridemia | |||||
APOE genotype | ε3/ε3 | 1 |  | 1 |  |
ε2 carrier | 1.12 (0.72–1.74) | 0.617 | 1.16 (0.72–1.86) | 0.538 | |
ε4 carrier | 1.15 (0.71–1.86) | 0.575 | 1.04 (0.62–1.75) | 0.869 | |
Hypercholesterolemia | |||||
APOE genotype | ε3/ε3 | 1 |  | 1 |  |
ε2 carrier | 0.64 (0.22–1.88) | 0.421 | 0.76 (0.26–2.26) | 0.624 | |
ε4 carrier | 1.82 (0.83–4.00) | 0.138 | 1.62 (0.70–3.77) | 0.259 | |
rs429358 Dominant | T/T | 1 | Â | 1 | Â |
Dyslipidemia | |||||
APOE genotype | ε3/ε3 | 1 |  | 1 |  |
ε2 carrier | 1.06(0.70–1.60) | 0.784 | 1.14 (0.73–1.77) | 0.564 | |
ε4 carrier | 1.36 (0.89–2.08) | 0.153 | 1.26 (0.80–1.99) | 0.312 |